Keybanc Upgrades Corteva to Overweight, Announces $17 Price Target
Keybanc analyst Salvator Tiano upgrades Corteva (NYSE:CTVA) from Sector Weight to Overweight and announces $17 price target.
Stocks · News reference
Cramer avoids Polaris, likes Forgent despite its valuation, finds Symbotic too expensive, and hasn’t reviewed Corteva; all four stocks fell.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Keybanc analyst Salvator Tiano upgrades Corteva (NYSE:CTVA) from Sector Weight to Overweight and announces $17 price target.
Corteva (CTVA) surged 12% following a JPMorgan upgrade to Overweight with a $19 price target, implying 37% upside. The rally was fueled by the company's separation from Vylor and its inclusion in the S&P MidCap 400. Trading at 5.7x 2027 EBITDA, Corteva is positioned as a deep-value opportunity in crop protection, though legal liabilities from PFAS/PFOA concerns remain a risk factor.
Corteva stock surged 12.99% following JPMorgan's upgrade to overweight with a $19 price target, implying 53.3% upside from the previous closing price of $12.39. The upgrade comes after Corteva's October spinoff of its advanced seed and genetics business, with JPMorgan believing the company is now undervalued. The crop protection segment has shown strong growth, with over $1 billion in sales increases and 250 basis points of margin expansion from 2020-2025.
S&P 500 and Nasdaq 100 hit records as the 10-year yield retreats from a 24-year high; Constellation Energy jumps on a Google nuclear deal.